Reply to the letter by I. Tasci regarding 'Clinical usefulness of AGEs as a biomarker for the attenuation of NASH'
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-07-01
著者
関連論文
- Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells
- A Nuclear Receptor-mediated Choleretic Action of Fibrates is Associated with Enhanced Canalicular Membrane Fluidity and Transporter Activity Mediating Bile Acid-independent Bile Secretion
- Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia : clinical usefulness of AGEs as a biomarker for the attenuation of NASH
- Reply to the letter by Y. Yilmaz regarding "the AGEs-RAGE axis and nonalcoholic steatohepatitis"
- A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease
- Reply to the letter by I. Tasci regarding 'Clinical usefulness of AGEs as a biomarker for the attenuation of NASH'
- Platelet count for predicting fibrosis in nonalcoholic fatty liver disease
- Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan : a multicenter large retrospective study
- Association between type 2 diabetes genetic susceptibility loci and visceral and subcutaneous fat area as determined by computed tomography
- Genetic variations in the CYP17A1 and NT5C2 genes are associated with a reduction in visceral and subcutaneous fat areas in Japanese women
- Computed tomography analysis of the association between the SH2B1 rs7498665 single-nucleotide polymorphism and visceral fat area
- Increased serum liver X receptor ligand oxysterols in patients with non-alcoholic fatty liver disease
- Efficacy of pitavastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia : An open-label, pilot study
- Recent trend of clinical features in patients with hepatocellular carcinoma
- Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits
- NUDT3 rs 206936 is associated with body mass index in obese Japanese women
- noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels